Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Lifecare AS ( (DE:LFC0) ) is now available.
Lifecare ASA has reminded investors of the ongoing exercise period for its Series 1 warrants, which allow holders to subscribe for new shares at NOK 0.3342 each until 16:30 CET on 13 March 2026, after which unexercised warrants will lapse without value and may dilute non‑participating shareholders. The company disclosed that CEO and primary insider Joacim Holter has exercised 600,000 warrants, and subject to timely payments, the resulting share capital increase is expected to be registered in late March, with new shares delivered to investors’ VPS accounts shortly thereafter.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes, with a primary emphasis on next‑generation continuous glucose monitoring systems. Its osmotic pressure‑based sensor platform is designed for detecting and tracking a broad range of analytes and molecules in humans and pets.
Average Trading Volume: 2,808,667
Current Market Cap: NOK77.38M
See more insights into LFC0 stock on TipRanks’ Stock Analysis page.